Antibody-drug Combo Shows Early Promise in Targeting Cancers, Company Says
News
BrickBio’s antibody-drug conjugate BRKB-28 showed preclinical effectiveness in eradicating breast cancer cells while leaving healthy cells unharmed, the company announced. BRKB-28 combines an antibody against a cancer protein with a ... Read more